News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
Presentation TCT 2024 TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design Presenter: Tomasz Skowerski October 28, 2024
News Conference News TCT 2022 Valve Fracture for ViV TAVI Linked With Higher Mortality Michael O'Riordan September 22, 2022
Presentation TCT 2019 Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial Presenter: Felix Mahfoud September 27, 2019
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News TCT 2015 Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored October 13, 2015
Presentation TCT 2012 Lone Surgical Treatment of Atrial Fibrillation: Meaningful Progress in the Past 15 Years? Presenter: William Cohn October 24, 2012
Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012